Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 18, 2008

View Archived Issues

Studies show analgesic efficacy of ARRY-797 in postsurgical dental pain

Pooled GOUT 1 and GOUT 2 data detail effects of pegloticase

Recent University of Aberdeen patent discloses novel agents for bone disorders

New therapeutic agents for neurological disorders reported in recent patent literature

Thalidomide not effective in treating amyotrophic lateral sclerosis

Antimicrobial activity of host defense peptide mimetics described

NIH awards SBIR grant to BioSante to develop pulmonary delivery of IFN-alpha

Boehringer Ingelheim commences phase III pivitol program for Vargatef

DSMC authorizes Bioniche to continue phase III Urocadin trial in bladder cancer

Innocoll receives FDA fast track designation for Gentamicin Surgical Implant

Relistor approved in Australia for opioid-induced constipation

Life Science Pharmaceuticals enters into agreement with Abbott for Antibody 806

Eli Lilly and United Therapeutics enter license and supply agreement for PAH

SciClone reaches agreement with FDA on SPA for phase III thymalfasin trial

Solvay discontinues R&D activities of antiobesity compound SLV-319

Theratechnologies completes treatment of patients in extension phase of tesamorelin trial

Biotie acquires Elbion NV's subsidiary Elbion GmbH

Proteome Systems changes name to Tyrian Diagnostics

Affymax completes enrollment in EMERALD 2 phase III clinical trial of Hematide

Serenity initiates phase II clinical study of intranasal drug for urology indication

Novel dopamine D3 receptor agonists and antagonists described by Pfizer

Preclinical activity of PF-03800130 shows benefit in bipolar disorder-associated mood symptoms

Phase II results with rivaroxaban in acute coronary syndromes reported

New compounds for hypogonadism described in recent GSK patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 13, 2026.
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal
BioWorld
In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...